„The graveyard of failed medical technology innovation – Lessons learned“ – Biotech Entrepreneurship and Leadership Lectures with Michael Ullmann, Johnson&Johnson
We are pleased to announce the next „Biotech Entrepreneurship and Leadership Lecture“. Michael Ullmann from Johnson&Johnson will speak about „The graveyard of failed medical technology innovation – Lessons learned„.
Before joining Johnson & Johnson in October 2017, Michael was the Chief Medical Expert at Robert Bosch GmbH Stuttgart from January 2012 to September 2017, where he jointly headed the Strategic Project Program “Healthcare Solutions” within Corporate Research and Advance Engineering. During this time, he scouted emerging medical topics and reported to researchers and top-management on a regular basis. In addition, he assessed and implemented innovative medical technology into research projects, which were later transferred to the business unit. He was not only responsible for medical, clinical, and scientific affairs within Corporate Research, but also developed and consolidated new business models. He wrote numerous invention reports and currently holds several medical technology patents. In his role as Chief Medical Expert, he reported directly to the board of Managing Directors and was member of numerous Bosch review and steering boards for all medical related activities. He was mainly involved in the strategic revision and decision-making process to align and prioritize the ongoing medtech projects. Furthermore, he consulted Robert Bosch Venture Capital in the assessment of (bio)medtech start-ups, and built up and fostered a broad network of key opinion leaders in the national and international medical and scientific community.
As a specialist in general & sports medicine, Michael run his own practice for about six years in Karlsruhe, Germany, before he joined Bosch. He is also a specialist in anti-aging and preventive medicine, metabolic disorders, high blood pressure, and a biofeedback therapist. In addition, he is a former surgeon with a specialist level in cardiac surgery and two years of general surgery (visceral, trauma, pediatric, and vascular surgery). During his academic career at several university hospitals across Europe, he authored numerous international peer-reviewed publications and held numerous talks. His interdisciplinary clinical research on flow-induced pulmonary hypertension at the University of Heidelberg was funded by a grant of the German Heart Foundation. He is a principal investigator in clinical trials, certified medical product consultant, and a former university lecturer HeiCuMed (Heidelberger Curriculum Medicinale).
He studied medicine at the University of Heidelberg and Medical Faculty of Montpellier, France, for one year, for which he was awarded with a scholarship of the German Academic Exchange Service. In November 2017, he obtained a MBA degree in business administration for medical doctors after successfully finishing a two years business studies at the University of Applied Science Neu-Ulm, Germany (pass with distinction).
When: Wednesday, April 11, 2018, 5:00-06:30 p.m.
Where: Marsilius Arkaden of Heidelberg University, Seminar Room 1, Im Neuenheimer Feld 130.1, Heidelberg
A registration for the lectures is not required.